Until 2015, there was no uniform definition of cutaneous lupus erythematosus (CLE), which made it difficult to identify a study population for observational and interventional trials .
In 2015, an expert group met for a consensus agreement and agreed that a single international classification scheme is needed to enable communication with patients and physicians . The lack of classification criteria led to heterogeneity in observational and interventional research efforts, stated Prof. Joseph F. Merola (Brigham and Women´s Hospital, Harvard Medical School, USA). Particularly striking was the absence of classification criteria for discoid lupus erythematosus (DLE), the most common type of CLE. Therefore, a list of 12 potential clinical and histopathologic items to serve as classification criteria of DLE was developed in 2017 (see Figure) . “This effort represented a key step towards the development of formal DLE classification criteria,” concluded P...
please login to read the entire article:
You need to register to read the entire article, please do so now.
« Skin toxicity of immune checkpoint inhibitors Next Article
Biologicals beyond TNF blockade »
Table of Contents: WCD 2019
Treating Psoriasis in 2019
Atopic Dermatitis – What is New
Dermal Reactions to Systemic Drugs
Lupus Erythematosus Today
Small Molecules – What to Expect
Optimising the Management of Keloids
Malignant Melanoma – Advances in Management
Best of the Posters
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.